The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
D004999:Amifostine / Q000627:therapeutic use*; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control*; D008558:Melphalan / Q000627:therapeutic use*; D051379:Mice; D008815:Mice, Inbred Strains; D008920:Misonidazole / Q000627:therapeutic use*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000188:drug therapy*
D009593:Nitroimidazoles; D009946:Organothiophosphorus Compounds; D008920:Misonidazole; D003520:Cyclophosphamide; D004999:Amifostine; D008558:Melphalan